caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1548464001

Geoffrey NeunerMD

Radiation OncologyBaltimore, MDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Geoffrey Neuner's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 20 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
GREATER BALTIMORE MEDICAL CENTER, INC.1782,741
LEVINE, MARSHALL50783
Quest Diagnostics Incorporated Md
Clinical Laboratory · Baltimore, MD
29167
KATZ, MYRA23227
Robert Palermo
Pathology · Baltimore, MD
2283
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
22126
Charles Yim
Diagnostic Radiology · Baltimore, MD
21136
SIEGEL, HOWARD21105
L Harris Mccorkle
Diagnostic Radiology · Baltimore, MD
20100
Nathan Dunsmore
Pathology · Baltimore, MD
1964
Mei Tang
Hematology-Oncology · Baltimore, MD
16134
PEARLMAN, STEVEN1567
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,331
Unique beneficiaries
—
Total services
6,524
Distinct HCPCS
29
Medicare payment
$792K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 95 Radiation Oncology providers in MD — top quintile (cohort median 2,543).
PRESCRIBING · PART D · 2024
Total Rx claims
165
Beneficiaries
—
Total drug cost
$2K
Distinct drugs
5
Brand share
22.4%
Top prescribed drugs
Tamsulosin Hcl108 claims
Finasteride20 claims
Oxybutynin Chloride14 claims
Lidocaine Hcl12 claims
Alfuzosin Hcl11 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$910
Payment records
17
By payment type
Food and Beverage$910